The Monday morning sessions were focused on historical topics to put things into perspective and frame discussions on current practices and challenges. Three important practice challenges were discussed: (1) the current status of bioresorbable scaffold development and Abbott Vascular's decision to pull their product from the market; (2) metallic bioresorbable stents; and (3) magnesium bioresorbable stents.
Faculty Disclosure Vendor Supporters Program Agenda IAGS Video Menu